1、单击此处编辑母版标题样式,单击此处编辑母版文本样式,第二级,第三级,第四级,第五级,2,#,CT,评估肺动脉高压与肺心病的临床价值,1,2,CT,评估肺动脉高压,2,2025/7/23 周三,现况,CT,评估肺动脉高压,3,2025/7/23 周三,目前研究,CT,评估肺动脉高压(,PAH,),主要集中于肺动脉内径(,PAD,)以及升主动脉与主肺动脉比值比(,rPA,)。,而越来越多的研究也证明其他,CT,指标如左、右心室内径比值(,RV/LV,)、室壁厚度、室间隔厚度也具有评估价值。,CT,评估,PAH,现况,1,、,Truong Q A,Massaro J M,Rogers I S,et
2、 al.Reference values for normal pulmonary artery dimensions by noncontrast cardiac computed tomography:the Framingham Heart Study.J.Circulation Cardiovascular Imaging,2012,5(1):147-54.,2,、,Corson N,Labby Z E,Straus C,et al.CT-based pulmonary artery measurements for the assessment of pulmonary hypert
3、ensionJ.Academic Radiology,2014,21(4):523-530.,4,2025/7/23 周三,Truong,等人报道,,706,名健康成人,,CT,测定,PAD,的正常值为男性,29mm,,女性,27mm,。,CT,评估,PAH,现况,Truong Q A,Massaro J M,Rogers I S,et al.Reference values for normal pulmonary artery dimensions by noncontrast cardiac computed tomography:the Framingham Heart Study.J
4、Circulation Cardiovascular Imaging,2012,5(1):147-54.,5,2025/7/23 周三,Chan,等人报道,,101,例急诊肺动脉高压患者,以,PAD29mm,作为肺动脉高压的诊断标准,其敏感度为,77.4,,特异度为,89.6,。,而右室壁厚度、,RV/LV,、肺动脉左右分支管径以及,rPA,均可以作为筛查肺动脉高压的参考指标。,CT,评估,PAH,现况,Chan A L,Juarez M M,Shelton D K,et al.Novel computed tomographic chest metrics to detect pulmon
5、ary hypertensionJ.BMC Medical Imaging,2011,11(1):7.,6,2025/7/23 周三,Lange,等人报道,以,PAD29mm,作为,26,例临界肺动脉高压的诊断标准,其敏感度为,77%,,特异度为,62%,。,CT,评估,PAH,现况,Lange T J,Dornia C,Stiefel J,et al.Increased pulmonary artery diameter on chest computed tomography can predict borderline pulmonary hypertensionJ.Pulmonary
6、Circulation,2013,3(2):363-368.,7,2025/7/23 周三,Corson,等人报道,,191,例患者以,rPA,作为肺动脉高压的诊断标准,其敏感度、特异度分别为,89%,、,82%,。,CT,评估,PAH,现况,Corson N,Labby Z E,Straus C,et al.CT-based pulmonary artery measurements for the assessment of pulmonary hypertensionJ.Academic Radiology,2014,21(4):523-530.,8,2025/7/23 周三,Condl
7、iffe,等人报道,,48,例肺动脉高压患者以,RV/LV,作为肺动脉高压的诊断标准,其敏感度为,80%,,特异度为,89%,。相比于,rPA,,,RV/LV,能更好地预测生存率。,CT,评估,PAH,现况,Condliffe R,Radon M,Hurdman J,et al.CT pulmonary angiography combined with echocardiography in suspected systemic sclerosis-associated pulmonary arterial hypertensionJ.Rheumatology,2011,50(8):1480
8、9,2025/7/23 周三,Condliffe,等人还报道了,CT-rPA,分别联合超声下三尖瓣返流速度,(TG),、,RV/LV,可以提高肺动脉高压筛查的准确率。,CT/echo composite index=0.27TG,29.355rPA,9.031,CT composite index=38.968rPA,8.589 RV/LV,16.057,CT,评估,PAH,现况,Condliffe R,Radon M,Hurdman J,et al.CT pulmonary angiography combined with echocardiography in suspected s
9、ystemic sclerosis-associated pulmonary arterial hypertensionJ.Rheumatology,2011,50(8):1480.,10,2025/7/23 周三,CT,目前也可以用于心功能及血流状态的评估。,Pienn,等人报道,,23,例肺动脉高压患者的对比剂流速及加速时间与对照组存在差异。,Reve,等人报道,心电门控,CT,测定的,45,例,PAH,患者,其心脏收缩期和舒张期时右肺动脉的横截面积会异常与常人,CT,由于容积效应、伪影以及造影剂不均匀分布等多种因素,导致,CT,下观察到的心脏结构多有误差。故相较于心脏,MRI,,,CT,
10、很少在临床上用于心功能及血流状态评估。,CT,评估,PAH,现况,1.Pienn M,Kovacs G,Tscherner M,et al.Non-invasive determination of pulmonary hypertension with dynamic contrast-enhanced computed tomography:a pilot study.J.European Radiology,2014,24(3):668.,2.,Revel M P,Faivre J B,Remy-Jardin M,et al.Pulmonary hypertension:ECG-gate
11、d 64-section CT angiographic evaluation of new functional parameters as diagnostic criteriaJ.Radiology,2009,250(2):558-566.,11,2025/7/23 周三,现本组,meta,分析,CT,评估肺动脉高压,12,2025/7/23 周三,检索数据库:,PubMed,Embase,Web of Science,。,检索词与策略:,“pulmonary hypertension”,,,“computer tomography”,,,“right heart catherizati
12、on”and“accuracy”,;语种:英文;其他无限制。,纳入标准:所有评估,CT,诊断肺动脉高压准确性的原创性全文;所有患者需行右心导管检查;,PAH,的诊断标准,25mmHg,。,排除标准:毛细血管前性,PAH,或心肺术后患者;无法提取出所需数据。,本组,meta,分析,13,2025/7/23 周三,现纳入研究,6,篇,共,395,人。,采用,QUADAS-2,量表对各研究进行质量评估,评分均大于,7,分,考虑纳入文献均为中高质量文献。,纳入各组间存在异质性(,I,2=,88.4%,,,Q,检验,p,0.01,)。由于纳入文献较少,暂无法对异质性进行讨论,考虑异质性可能与,PAH,原
13、发病、年龄、性别构成以及各组研究设计等因素有关。,无发表偏移。,本组,meta,分析,14,2025/7/23 周三,本组,meta,分析,1,Shen Y,Wan C,Tian P,et al.CT-Base Pulmonary Artery Measurementin the Detection of Pulmonary Hypertension:A Meta-Analysis and Systematic ReviewJ.Medicine,2014,93(27):e256.,2,Taleb M,Khuder S,Tinkel J,et al.The diagnostic accuracy
14、 of Doppler echocardiography in assessment of pulmonary artery systolic pressure:a meta-analysisJ.Echocardiography,2013,30(3):258-265.,3.Shao F C.Diagnostic value of transthoracic Doppler echocardiography in pulmonary hypertension:a meta-analysis.J.American Journal of Hypertension,2010,23(12):1261-4
15、研究,文献数,患者数,RHC,金标准,研究对象,研究指标,合并灵敏度,合并特异度,本组,6,395,全部,CT,PAD,0.79(95%CI,0.730.84,),0.73(95%CI,0.660.79),Shen,等,20,2134,部分,CT,PAD,0.79(95%CI,0.720.84,),0.83(95%CI,0.750.89),rPA,0.74(95%CI,0.660.80),0.81(95%CI,0.740.76),Taleb,等,9,482,全部,超声,-,0.88(95%CI,0.840.92,),0.56(95%CI,0.460.66),Shao,等,6,706,全部,
16、超声,RVSP,0.82(,95%CI,,,0.760.88),0.68,(95%CI,0.640.72),15,2025/7/23 周三,目前多篇报道认为,CT,具有诊断,PAH,的潜在价值。但目前其诊断效能相较超声并未展现明显优势,而其相较于超声的操作复杂、费用较高、极大辐射以及造影剂过敏风险,使其无法作为,PAH,筛查的一线无创性手段。且目前关于,CT,的研究多局限于回顾性研究以及继发性肺动脉高压,对于特发性肺动脉高压的诊断以及相应前瞻性研究仍需进一步开展。所以,,CT,目前多用于继发性,PAH,的肺部评估,以及超声疑诊,PAH,的辅助筛查手段。,总结,16,2025/7/23 周三,C
17、T,评估肺心病,17,2025/7/23 周三,现况,CT,评估肺心病,18,2025/7/23 周三,目前外文文献已很少采用“肺心病”,但,由于我国肺心病的病人基数较大,,,目前肺心病这一词语仍在临床上使用。,目前关于,CT,评估肺心病的文献较少。,CT,评估肺心病现况,1,、,MacNee W.Pathophysiology of cor pulmonale in chronic obstructive pulmonary diseaseJ.Am J Respir Crit Care Med,1994,150:833-852.,2,、,2017,Global strategy for th
18、e diagnosis,management,and prevention of chronic obstructive pulmonary disease.,19,2025/7/23 周三,Gao,等人报道,,63,例,COPD,合并慢性肺源性心脏病患者通过,CT,测定,其,RV-EF,以及,RV,随病情发生了明显变化。,CT,评估肺心病现况,Gao Y,Du X,Liang L,et al.Evaluation of right ventricular function by 64-row CT in patients with chronic obstructive pulmonary
19、disease and cor pulmonaleJ.European Journal of Radiology,2012,81(2):345-353.,20,2025/7/23 周三,我院,109,例病人,取,CT-PAD,29mm,时判断肺源性心脏病,其,OR,为,16.48,(,95%CI,:,5.6-48.8,,,p,0.01,)。,CT,测定,PAD,可以作为肺心病独立诊断指标。,本组既往研究,杨耸,吴尚洁,.,慢性肺部病变过程与主肺动脉直径的关系,J.,中南大学学报,:,医学版,2015,40(10):1138-1142.DOI:10.11817/j.issn.1672-7347.
20、2015.10.014,21,2025/7/23 周三,现本组回顾性研究,CT,评估肺心病,22,2025/7/23 周三,肺源性心脏病,作为,COPD,及缺氧性肺动脉高压,的晚期并发症之一,,死亡风险较大。,目前仍以代偿期以及失代偿其对肺心病进行病情评估,同时另一分期指标,FEV1,本身存在较大的变异性,而频繁急性加重(每年,2,次)缺乏前瞻性以及量化性。这导致这些晚期病人缺乏有效的病情评估及管理方式。,肺源性心脏病,是缺氧性肺动脉高压的终末期事件,结合既往研究,回顾性分析,CT-PAD,与肺心病频繁急性加重之间的关系。,本组回顾性研究,2017,Global strategy for th
21、e diagnosis,management,and prevention of chronic obstructive pulmonary disease.,23,2025/7/23 周三,纳入,/,排除标准:我院诊断为肺心病或其他相应慢性肺部患者,,收集对照组时匹配慢性肺疾病组的男女比以及年龄层。,无胸部各结构破坏及手术外伤史。,对收集病人进行,WHO-FC,分级、,1,年内急性加重次数统计以及超声、,CT,相关数据收集。,纳入我院,107,例病人,,对照组,13,例,,COPD27,例,肺心病代偿期,37,例,肺心病失代偿期组,30,例,性别、年龄、体重匹配。,本组回顾性研究,24,20
22、25/7/23 周三,PAD,与急性加重次数高度相关(,r=0.87,,,P,0.05,),。,急性加重次数与,WHO-FC,分级,r=0.42,P0.05,、三尖瓣反流速度(,r=0.44,,,P,0.05,)低度相关。,本组回顾性研究,25,2025/7/23 周三,使用,CT-PAD,35mm,预测肺心病患者频繁急性加重(每年,2,次),,敏感度,0.896,,特异度,0.949,,,AUC,为,0.962,,,OR,为,160.5,(,95%CI,:,36.3-709.1,,,p0.01),。,本组回顾性研究,26,2025/7/23 周三,目前关于,CT,评估肺心病的文献较少,但多项,CT,指标(,RV-EF,、,RV,、,PAD,等)可以有效评估右心功能,并能对肺心病的发生发展做出评价。,目前此类研究多为回顾性小样本实验,需要前瞻性、大样本、多中心实验进行进一步评估。,总结,27,2025/7/23 周三,






